The Heart and COVID-19: What Cardiologists Need to Know

Isabela Bispo Santos da Silva Costa1,2, Cristina Salvadori Bittar1,2, Stephanie Itala Rizk1,2

  • 1Universidade de São Paulo - Instituto do Câncer do Estado de São Paulo, São Paulo, SP - Brasil.

Insights

Managing patients with cardiovascular disease during the COVID-19 pandemic is complex. Cardiovascular complications arise from viral injury, inflammation, and thrombosis, necessitating focused cardiac care for improved patient outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The novel coronavirus disease 2019 (COVID-19) pandemic presents significant challenges in managing patients with pre-existing cardiovascular conditions.
  • Cardiovascular complications in COVID-19 patients stem from direct viral effects, systemic inflammation, and pro-thrombotic states.

Purpose of the Study:

  • To highlight the complexities of managing cardiovascular disease in the context of COVID-19.
  • To underscore the importance of addressing cardiovascular system needs for optimal patient care during the pandemic.

Main Methods:

  • Review of current literature on COVID-19 and cardiovascular complications.
  • Analysis of mechanisms underlying cardiovascular manifestations in COVID-19 patients.

Main Results:

  • COVID-19 significantly impacts patients with cardiovascular risk factors and diseases.
  • Multiple pathways, including direct viral damage and immune responses, contribute to cardiovascular complications.

Conclusions:

  • Specialized attention to the cardiovascular system is crucial for improving outcomes in COVID-19 patients.
  • Integrated care strategies are needed to manage cardiovascular aspects of COVID-19 effectively.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
393
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
Layers of the Heart Wall01:15

Layers of the Heart Wall

The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
4.7K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
220